Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Bio-Rad Laboratories B | BIO-B | Nov 13, 2024 | 334.85 | 0.00 |
Bio-Techne | TECH | Nov 13, 2024 | 75.93 | +2.04 |
BioAffinity Technologies | BIAF | Nov 13, 2024 | 1.29 | +0.78 |
BioAtla | BCAB | Nov 13, 2024 | 1.99 | -9.13 |
BioCardia | BCDA | Nov 13, 2024 | 2.35 | -2.08 |
Bioceres Crop Solutions | BIOX | Nov 13, 2024 | 6.84 | +2.78 |
BioCryst Pharmaceuticals | BCRX | Nov 13, 2024 | 7.64 | -2.30 |
Biodesix | BDSX | Nov 13, 2024 | 1.40 | 0.00 |
Biodexa Pharma ADR | BDRX | Nov 13, 2024 | 4.85 | -3.39 |
Biofrontera | BFRI | Nov 13, 2024 | 0.83 | -11.54 |
Biogen | BIIB | Nov 13, 2024 | 165.79 | -1.48 |
Biohaven | BHVN | Nov 13, 2024 | 49.04 | -2.62 |
BioLife Solutions | BLFS | Nov 13, 2024 | 24.11 | -9.02 |
BioLineRX ADR | BLRX | Nov 13, 2024 | 0.45 | +5.26 |
BioMarin Pharmaceutical | BMRN | Nov 13, 2024 | 66.66 | +0.80 |
Biomea Fusion | BMEA | Nov 13, 2024 | 7.09 | -11.42 |
Biomerica | BMRA | Nov 13, 2024 | 0.36 | -1.76 |
BiomX | PHGE | Nov 13, 2024 | 0.72 | -6.33 |
Bionano Genomics | BNGO | Nov 13, 2024 | 0.28 | +4.53 |
BioNexus Gene Lab | BGLC | Nov 13, 2024 | 0.32 | -2.03 |
Bionomics ADR | BNOX | Nov 13, 2024 | 0.29 | -7.63 |
BioNTech ADR | BNTX | Nov 13, 2024 | 111.48 | +4.85 |
Biora Therapeutics | BIOR | Nov 13, 2024 | 2.49 | -7.78 |
BioRestorative Therapies | BRTX | Nov 13, 2024 | 1.54 | -6.10 |
BioShares Biotechnology Clinical Trials Fund | BBC | Nov 13, 2024 | 29.28 | -1.84 |
BioShares Biotechnology Products Fund | BBP | Nov 13, 2024 | 65.21 | -0.67 |
biote | BTMD | Nov 13, 2024 | 6.72 | +21.74 |
Bioventus A | BVS | Nov 13, 2024 | 11.16 | -5.74 |
BioVie | BIVI | Nov 13, 2024 | 3.41 | +1.79 |
BioXcel Therapeutics | BTAI | Nov 13, 2024 | 0.62 | -6.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.